Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Development and Validation of the Lymphedema Symptom and Intensity Survey-Arm

Identifieur interne : 003953 ( Pmc/Curation ); précédent : 003952; suivant : 003954

Development and Validation of the Lymphedema Symptom and Intensity Survey-Arm

Auteurs : Sheila H. Ridner ; Mary S. Dietrich

Source :

RBID : PMC:4554806

Abstract

Purpose

The purpose of this instrument development project was to create a self-report tool to evaluate arm lymphedema and associated symptoms in breast cancer survivors.

Methods

The Lymphedema Symptom Intensity and Distress Survey-Arm (LSIDS-A) was developed and tested in three phases: Phase One--literature review and expert panel, Phase Two--preliminary validation, and Phase Three--final validation.

Results

Phase One: The most common symptoms experienced by breast cancer survivors with lymphedema were identified. A 52-item scale was developed. Phase Two: 128 community-dwelling breast cancer survivors (64 with lymphedema, 64 without lymphedema) completed the LSIDS-A. Feedback from the participants was that the format was “clear” and “made sense”; therefore, the response structure was left intact. Sixteen items were deleted leaving a 36-item revised instrument. Phase Three: Subsequent testing in a total sample of 236 breast cancer survivors with lymphedema was undertaken. The Cronbach's alpha reliability values for the overall intensity and distress scores were 0.93 and 0.94 respectively. The Kuder-Richardson values ranged from 0.66 to 0.92. Divergent validity evaluated against Marlowe-Crowne Social Desireability Scale overall was acceptable (intensity: rs = 0.08, distress: rs = -0.12). Convergent validity was acceptable as tested with multiple instruments (e.g., Functional Assessment of Cancer Therapy-Breast +4, overall intensity rs = -0.44, overall distress rs = -.48)

Conclusions

The 30-item LSIDS-A is a valid and reliable instrument that can be used to assess arm lymphedema and its associated symptoms.


Url:
DOI: 10.1007/s00520-015-2684-y
PubMed: 25752884
PubMed Central: 4554806

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:4554806

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Development and Validation of the Lymphedema Symptom and Intensity Survey-Arm</title>
<author>
<name sortKey="Ridner, Sheila H" sort="Ridner, Sheila H" uniqKey="Ridner S" first="Sheila H." last="Ridner">Sheila H. Ridner</name>
</author>
<author>
<name sortKey="Dietrich, Mary S" sort="Dietrich, Mary S" uniqKey="Dietrich M" first="Mary S." last="Dietrich">Mary S. Dietrich</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">25752884</idno>
<idno type="pmc">4554806</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554806</idno>
<idno type="RBID">PMC:4554806</idno>
<idno type="doi">10.1007/s00520-015-2684-y</idno>
<date when="2015">2015</date>
<idno type="wicri:Area/Pmc/Corpus">003954</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003954</idno>
<idno type="wicri:Area/Pmc/Curation">003953</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003953</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Development and Validation of the Lymphedema Symptom and Intensity Survey-Arm</title>
<author>
<name sortKey="Ridner, Sheila H" sort="Ridner, Sheila H" uniqKey="Ridner S" first="Sheila H." last="Ridner">Sheila H. Ridner</name>
</author>
<author>
<name sortKey="Dietrich, Mary S" sort="Dietrich, Mary S" uniqKey="Dietrich M" first="Mary S." last="Dietrich">Mary S. Dietrich</name>
</author>
</analytic>
<series>
<title level="j">Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</title>
<idno type="ISSN">0941-4355</idno>
<idno type="eISSN">1433-7339</idno>
<imprint>
<date when="2015">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<sec id="S1">
<title>Purpose</title>
<p id="P1">The purpose of this instrument development project was to create a self-report tool to evaluate arm lymphedema and associated symptoms in breast cancer survivors.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">The Lymphedema Symptom Intensity and Distress Survey-Arm (LSIDS-A) was developed and tested in three phases:
<italic>Phase One</italic>
--literature review and expert panel,
<italic>Phase Two</italic>
--preliminary validation, and
<italic>Phase Three</italic>
--final validation.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">
<italic>Phase One</italic>
: The most common symptoms experienced by breast cancer survivors with lymphedema were identified. A 52-item scale was developed.
<italic>Phase Two</italic>
: 128 community-dwelling breast cancer survivors (64 with lymphedema, 64 without lymphedema) completed the LSIDS-A. Feedback from the participants was that the format was “clear” and “made sense”; therefore, the response structure was left intact. Sixteen items were deleted leaving a 36-item revised instrument.
<italic>Phase Three</italic>
: Subsequent testing in a total sample of 236 breast cancer survivors with lymphedema was undertaken. The Cronbach's alpha reliability values for the overall intensity and distress scores were 0.93 and 0.94 respectively. The Kuder-Richardson values ranged from 0.66 to 0.92. Divergent validity evaluated against Marlowe-Crowne Social Desireability Scale overall was acceptable (intensity:
<italic>r
<sub>s</sub>
=</italic>
0.08, distress:
<italic>r
<sub>s</sub>
</italic>
= -0.12). Convergent validity was acceptable as tested with multiple instruments (e.g., Functional Assessment of Cancer Therapy-Breast +4, overall intensity
<italic>r
<sub>s</sub>
=</italic>
-0.44, overall distress
<italic>r
<sub>s</sub>
=</italic>
-.48)</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">The 30-item LSIDS-A is a valid and reliable instrument that can be used to assess arm lymphedema and its associated symptoms.</p>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9302957</journal-id>
<journal-id journal-id-type="pubmed-jr-id">8479</journal-id>
<journal-id journal-id-type="nlm-ta">Support Care Cancer</journal-id>
<journal-id journal-id-type="iso-abbrev">Support Care Cancer</journal-id>
<journal-title-group>
<journal-title>Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer</journal-title>
</journal-title-group>
<issn pub-type="ppub">0941-4355</issn>
<issn pub-type="epub">1433-7339</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">25752884</article-id>
<article-id pub-id-type="pmc">4554806</article-id>
<article-id pub-id-type="doi">10.1007/s00520-015-2684-y</article-id>
<article-id pub-id-type="manuscript">NIHMS670781</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Development and Validation of the Lymphedema Symptom and Intensity Survey-Arm</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ridner</surname>
<given-names>Sheila H.</given-names>
</name>
<degrees>PhD, RN, FAAN</degrees>
<aff id="A1">Vanderbilt University School of Nursing</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dietrich</surname>
<given-names>Mary S.</given-names>
</name>
<degrees>PhD</degrees>
<aff id="A2">Vanderbilt University School of Nursing</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="CR1">Vanderbilt University School of Nursing 461 21
<sup>st</sup>
Avenue South, Godchaux Hall Nashville, TN 37240 Phone: 615-322-0831 Fax: 615-343-7788
<email>sheila.ridner@vanderbilt.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>7</day>
<month>4</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>10</day>
<month>3</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>10</month>
<year>2016</year>
</pub-date>
<volume>23</volume>
<issue>10</issue>
<fpage>3103</fpage>
<lpage>3112</lpage>
<pmc-comment>elocation-id from pubmed: 10.1007/s00520-015-2684-y</pmc-comment>
<abstract>
<sec id="S1">
<title>Purpose</title>
<p id="P1">The purpose of this instrument development project was to create a self-report tool to evaluate arm lymphedema and associated symptoms in breast cancer survivors.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">The Lymphedema Symptom Intensity and Distress Survey-Arm (LSIDS-A) was developed and tested in three phases:
<italic>Phase One</italic>
--literature review and expert panel,
<italic>Phase Two</italic>
--preliminary validation, and
<italic>Phase Three</italic>
--final validation.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">
<italic>Phase One</italic>
: The most common symptoms experienced by breast cancer survivors with lymphedema were identified. A 52-item scale was developed.
<italic>Phase Two</italic>
: 128 community-dwelling breast cancer survivors (64 with lymphedema, 64 without lymphedema) completed the LSIDS-A. Feedback from the participants was that the format was “clear” and “made sense”; therefore, the response structure was left intact. Sixteen items were deleted leaving a 36-item revised instrument.
<italic>Phase Three</italic>
: Subsequent testing in a total sample of 236 breast cancer survivors with lymphedema was undertaken. The Cronbach's alpha reliability values for the overall intensity and distress scores were 0.93 and 0.94 respectively. The Kuder-Richardson values ranged from 0.66 to 0.92. Divergent validity evaluated against Marlowe-Crowne Social Desireability Scale overall was acceptable (intensity:
<italic>r
<sub>s</sub>
=</italic>
0.08, distress:
<italic>r
<sub>s</sub>
</italic>
= -0.12). Convergent validity was acceptable as tested with multiple instruments (e.g., Functional Assessment of Cancer Therapy-Breast +4, overall intensity
<italic>r
<sub>s</sub>
=</italic>
-0.44, overall distress
<italic>r
<sub>s</sub>
=</italic>
-.48)</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">The 30-item LSIDS-A is a valid and reliable instrument that can be used to assess arm lymphedema and its associated symptoms.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Lymphedema</kwd>
<kwd>instrument development</kwd>
<kwd>symptoms</kwd>
<kwd>distress</kwd>
<kwd>intensity</kwd>
<kwd>survey</kwd>
<kwd>breast cancer</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003953 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 003953 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Pmc
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:4554806
   |texte=   Development and Validation of the Lymphedema Symptom and Intensity Survey-Arm
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i   -Sk "pubmed:25752884" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024